Semax

Semax is a synthetic peptide derived from a fragment of the adrenocorticotropic hormone (ACTH) sequence, structurally modified for increased resistance to enzymatic degradation. It belongs to the class of regulatory neuropeptides and is offered here in injectable form as a reference compound within the Cognitive and Longevity category. Semax is supplied strictly for laboratory research and professional reference use and is not approved by the FDA for therapeutic use. Within the scientific literature, it is of general interest to investigators examining neuropeptide signaling, cognitive performance models, and neuroprotective pathways. This entry is provided as professional reference information for licensed ordering practitioners and does not constitute a therapeutic claim. Individual results vary.

• Investigated in preclinical and exploratory literature in relation to cognitive performance markers such as attention, learning, and working memory in research models; individual results vary
• Studied in research settings for its proposed relationship to neurotrophic and neuroprotective signaling pathways
• Examined in the literature in the context of neuronal response to ischemic or oxidative stress in experimental models
• Explored as a research probe for modulation of the brain-derived neurotrophic factor (BDNF) system and related signaling
• Of research interest with respect to mood- and stress-response pathways in preclinical investigation

Reference handling information: Lyophilized Semax is commonly reconstituted with bacteriostatic water (or sterile water per the receiving laboratory's standard practice), adding the diluent slowly against the vial wall and gently swirling rather than shaking until fully dissolved. Prior to reconstitution, the sealed lyophilized vial is typically stored in a cool, dry location away from direct light, with refrigeration or freezing commonly referenced for extended storage. After reconstitution, the solution is generally kept refrigerated at approximately 2-8 degrees C, protected from light and heat. Repeated freeze-thaw cycles are typically avoided, vials are kept tightly sealed, and the solution is inspected for particulates or discoloration before use. All clinical protocols, dosing, handling decisions, and applications are determined solely by the licensed ordering provider in the exercise of independent professional judgment; this is reference information only and does not constitute medical advice.

A per-lot Certificate of Analysis, HPLC purity profile, and mass-spectrometry verification are available on request for this product. Ask your account manager for the current lot documentation.

The proposed mechanism described in the research literature centers on Semax acting as a regulatory peptide that interacts with central nervous system signaling pathways. Research has reported that it may influence expression and activity of neurotrophic factors, including brain-derived neurotrophic factor (BDNF) and associated receptor signaling, as well as modulating components of the cholinergic, dopaminergic, and serotonergic systems in experimental models. Investigators have also examined its proposed effects on antioxidant and anti-inflammatory pathways relevant to neuronal resilience. These mechanisms are described as proposed or under study rather than established; individual results vary, and reported findings are derived primarily from preclinical and laboratory research.